CoChat

Effect of Mirtazapine Treatment on Serum Levels of Brain-Derived Neurotrophic Factor and Tumor Necrosis Factor-α in Patients of Major Depressive Disorder with Severe Depression

Gupta, Rachna, Gupta, Keshav, Tripathi, A.K., Bhatia, M.S., Gupta, Lalit K. · 2016 · Pharmacology

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

BACKGROUND: This study evaluated the clinical efficacy of mirtazapine and its effect on serum brain-derived neurotrophic factor (BDNF) and tumor necrosis factor-α (TNF-α) levels in patients of major-depressive disorder (MDD) with severe depression. METHODS: Patients (aged 18-60) with MDD diagnosed by DSM-IV criteria, and Hamilton Rating Scale for Depression (HAM-D) score ≥25 were included (n = 30). Mirtazapine was given in the doses of 30 mg/day. All patients were followed up for 12 weeks for the evaluation of clinical efficacy, safety along with serum BDNF and TNF-α levels. RESULTS: HAM-D score at the start of treatment was 30.1 ± 1.92, which significantly (p < 0.05) reduced to 13.47 ± 1.77 at 12 weeks of treatment. In responders, mean serum BDNF levels at the start of treatment were 2.32 ± 0.3 ng/ml, which significantly (p < 0.05) increased to 2.79 ± 0.33 ng/ml at 12 weeks of treatment and mean serum TNF-α levels at the start were 5.18 ± 0.67 pg/ml, which significantly decreased to 4.36 ± 0.72 pg/ml (p < 0.05) at 12 weeks of treatment. CONCLUSION: Our results suggest that mirtazapine is effective and well tolerated in severely depressed patients and treatment response is associated with an increase in serum BDNF and a decrease in serum TNF-α levels.

Overview

Integrity signals

Registry

Crossref · 10.1159/000444220

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 63

Metadata

Authors
Gupta, R., Gupta, K., Tripathi, A. K., Bhatia, M. S., & Gupta, L. K.
Affiliations
  • University College of Medical Sciences (IN)
  • Lady Hardinge Medical College (IN)
Venue
Pharmacology
Publisher
S. Karger AG
Published
2016
Volume
97
Issue
3-4
Pages
184-188
ISSN
  • 0031-7012 (ISSN-L)
  • 1423-0313
OpenAlex
W2265991184
Cited by
61
References
28
Citations by year
2026: 6 · 2025: 7 · 2024: 1 · 2023: 8 · 2022: 4 · 2021: 11 · 2020: 3 · 2019: 7 · 2018: 8 · 2017: 4 · 2016: 2
FWCI
5.67
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
mirtazapine, major depressive disorder, severe depression, brain-derived neurotrophic factor, TNF-α, serum biomarkers, antidepressant efficacy, treatment response, drug safety
MeSH terms
Mirtazapine, Adolescent, Adult, Antidepressive Agents, Tricyclic, Depression, Major Depressive Disorder, Depressive Disorder, Major, Female, Humans, Male, Mianserin, Middle Aged, Tumor Necrosis Factor-alpha, Treatment Outcome, Brain-Derived Neurotrophic Factor, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.